Fig. 3From: Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapya The root-mean-square dose (RMSD) volume histograms of SPArc (solid line) and RO-IMPT (dashed line) for patient 6. b The average areas under the RVH curve (AUC) for fourteen patients (b) with p-values on the top of the columnsBack to article page